Recanati-Miller Transplantation Institute, the Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
Department of General Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Clin Transplant. 2022 Sep;36(9):e14778. doi: 10.1111/ctr.14778. Epub 2022 Aug 3.
During the donor hepatectomy time (dHT), defined as the time from the start of cold perfusion to the end of the hepatectomy, liver grafts have a suboptimal temperature. The aim of this study was to analyze the impact of prolonged dHT on outcomes in donation after circulatory death (DCD) liver transplantation (LT).
Using the US national registry data between 2012 and 2020, DCD LT patients were separated into two groups based on their dHT: standard dHT (< 42 min) and prolonged dHT (≥42 min).
There were 3810 DCD LTs during the study period. Median dHT was 32 min (interquartile range 25-41 min). Kaplan-Meier graft survival curves demonstrated inferior outcomes in the prolonged dHT group at 1-year after DCD LT compared to those in the standard dHT group (85.3% vs 89.9%; P < .01). Multivariate Cox proportional hazards models for 1-year graft survival identified that prolonged dHT [hazard ratio (HR) 1.46, 95% confidence interval (CI) 1.19 - 1.79], recipient age ≥ 64 years (HR 1.40, 95% CI 1.14 - 1.72), and MELD score ≥ 24 (HR 1.43, 95% CI 1.16 - 1.76) were significant predictors of 1-year graft loss. Spline analysis shows that the dHT effects on the risk for 1-year graft loss with an increase in the slope after median dHT of 32 min.
Prolonged dHTs significantly reduced graft and patient survival after DCD LT. Because dHT is a modifiable factor, donor surgeons should take on cases with caution by setting the dHT target of < 32 min.
在供肝切取时间(dHT)期间,即从冷灌注开始到肝切除术结束的时间,肝移植物的温度不理想。本研究旨在分析在捐赠者循环死亡(DCD)肝移植(LT)中,dHT 延长对结局的影响。
使用美国国家注册数据,将 2012 年至 2020 年期间的 DCD LT 患者根据 dHT 分为两组:标准 dHT(<42 分钟)和延长 dHT(≥42 分钟)。
研究期间共有 3810 例 DCD LT。dHT 的中位数为 32 分钟(四分位距 25-41 分钟)。Kaplan-Meier 移植物生存曲线显示,与标准 dHT 组相比,DCD LT 后 1 年延长 dHT 组的结果较差(85.3% vs 89.9%;P<.01)。1 年移植物生存率的多变量 Cox 比例风险模型确定,延长 dHT[风险比(HR)1.46,95%置信区间(CI)1.19-1.79]、受体年龄≥64 岁(HR 1.40,95%CI 1.14-1.72)和 MELD 评分≥24(HR 1.43,95%CI 1.16-1.76)是 1 年移植物丢失的显著预测因子。样条分析显示,在 dHT 中位数为 32 分钟后,dHT 对 1 年移植物丢失风险的影响斜率增加。
DCD LT 后,dHT 时间延长显著降低了移植物和患者的生存率。由于 dHT 是一个可改变的因素,供体外科医生应谨慎对待,将 dHT 目标设定为<32 分钟。